Temasek could reportedly invest in CureFit at a valuation of $800m, less than six months after Unilever Ventures participated in a $120m round for the wellness services provider.

CureFit, an India-based healthcare and wellness services provider backed by consumer goods conglomerate Unilever, has entered discussions with Singaporean state-owned investment firm Temasek to raise $100m, LiveMint reported today. The company is targeting a valuation of approximately $800m, up from $575m six months ago. The deal is expected to close within six to eight weeks…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.